Moro L., Gazzarrini C., Crivellari D., Galligioni E., Talamini R., de Bernard B.
Biochemical markers for detecting bone metastases in patients with breast cancer // Clin.
Chem. — 1993. — V. 39(1). — P. 131 134.
Moseley J.M., Kubota M., Diefenbach+Jagger H.
è ñîàâò. Parathyroid hormone
related protein purified from a human lung cancer cell line // Proc. Natl. Acad. Sci. —
1987. — V. 84. — P. 5048 5052.
Mouridsen H.T., Ellemann K., Mattsson W., Palshof T., Daehnfeldt J.L., Rose C.
Therapic effect of tamoxifen versus tamoxifen combined with medroxyprogesterone
acetate in advanced breast cancer in postmenopausal women // Cancer Treat. Rep. —
1979. — V. 63. — P. 171 175.
Muggia F. M., Heinemann H.O.
Hypercalciemia associated with neoplastic disease
// Ann. Intern. Med. — 1970. — V. 73. — P. 281 290.
Mughal A.W., Hortobagyi G.N., Fritsch H.A
. è ñîàâò. Serial plasma carcinoembry
onic antigen level measurements during treatment of metastatic breast cancer // J.A.M.A. —
1983. — V. 249. — P.1881 1886.
Muindi J., Coombes R.C., Golding S., Powles T.J., Kahn O., Husband J.E.
The role of
computed tomography in the detection of bone metastases in breast cancer patients // Br.
J. Radiol. — 1983. — V. 56. — P. 233 236.
Mundy G.R., Luben R.A., Raisz L.G., Oppenheim J.J., Buell D.N.
Bone resorbing
activity in supernatans from lymphoid cell lines // N. Engl. J. Med. — 1974. — V. 290. —
P. 867 871.
Mundy G.R., Ibbotson K.J., D
,
Souza S.M., Simpson E.L., Jacobs J.W., Martin T.J.
The hypercalcaemia of cancer: clinical implications and pathogenic mechanisms // N.
Engl. J. Med. — 1984. — V. 310. — P. 1718 1726.
Mundy G.R.., Ibbotson K.J., D
,
Souza S.M.
Tumor products and the hypercalcaemia
of malignancy // J. Clin. Invest. — 1985. — V. 76. — P. 391 394.
Mundy G.R..
Hypercalcaemia of malignancy revisited // J. Clin. Invest. — 1988. —
V. 82. — P. 1 6.
Mundy G.R..
Mechanisms of osteolytic bone destruction // Bone. — 1990. —V. 12. —
P. 1 6.
Mundy G.R.
Incidence and pathophysiology of hypercalcemia // Calcif. Tissue Int. —
1990. — V. 46 (suppl.). — P. 3 10.
Mundy G.R.
Mechanisms of osteolytic bone destruction // Bone. — 1991. — V. 12.
(suppl.). — P. 1 6.
Mundy G.R..
Mechanisms of bone metastasis // Cancer. — 1997. —V. 80(Suppl. 8). —
P. 1546 1556.
Mundy G.R..
Preclinical studies of metastases: experimental models and novel tech
niques to detect micrometastases // Program and abstracts of 22nd San Antonio Breast
Cancer Symposium; December 8 11, 1999; San Antonio, Texas. (Mini symposium II:
Micrometastases: biology, clinical relevance, and treatment.
Murray R.M.L., Pitt P.
Medical adrenalectomy in patients with advanced breast can
cer resistant to anti oestrogen treatment // Breast Cancer Res. Treat. — 1981. — V.1. —
P. 91 95.
Murray P., Pitt P.
Treatment of advanced breast cancer with formestane // Ann.
Oncol. –1994. — V. 7(suppl. 5). — P. 11 13.
Muss H.B., Howard V., Richards R.
è ñîàâò. Cyclophosphamide versus cyclophos
phamide, methotrexate and 5 fluorouracil in advanced prostatic cancer: a randomized trial
// Cancer. — 1981. — V. 47. — P. 1942 1953.
239
Êîñòíûå ìåòàñòàçû ðàêà ìîëî÷íîé æåëåçû
